- Home
- FRBA vs RGNX Comparison
FRBA vs RGNX Comparison
Compare FRBA & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRBA
- RGNX
- Stock Information
- Founded
- FRBA 2007
- RGNX 2008
- Country
- FRBA United States
- RGNX United States
- Employees
- FRBA N/A
- RGNX N/A
- Industry
- FRBA Major Banks
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FRBA Finance
- RGNX Health Care
- Exchange
- FRBA Nasdaq
- RGNX Nasdaq
- Market Cap
- FRBA 364.6M
- RGNX 424.8M
- IPO Year
- FRBA N/A
- RGNX 2015
- Fundamental
- Price
- FRBA $14.95
- RGNX $8.10
- Analyst Decision
- FRBA Strong Buy
- RGNX Strong Buy
- Analyst Count
- FRBA 2
- RGNX 8
- Target Price
- FRBA $18.00
- RGNX $31.75
- AVG Volume (30 Days)
- FRBA 45.6K
- RGNX 546.0K
- Earning Date
- FRBA 07-22-2025
- RGNX 08-07-2025
- Dividend Yield
- FRBA 1.62%
- RGNX N/A
- EPS Growth
- FRBA 22.16
- RGNX N/A
- EPS
- FRBA 1.51
- RGNX N/A
- Revenue
- FRBA $131,202,000.00
- RGNX $156,718,000.00
- Revenue This Year
- FRBA $10.99
- RGNX $327.08
- Revenue Next Year
- FRBA $6.16
- RGNX N/A
- P/E Ratio
- FRBA $9.79
- RGNX N/A
- Revenue Growth
- FRBA 14.51
- RGNX 80.70
- 52 Week Low
- FRBA $12.74
- RGNX $5.04
- 52 Week High
- FRBA $16.47
- RGNX $13.48
- Technical
- Relative Strength Index (RSI)
- FRBA 43.20
- RGNX 45.17
- Support Level
- FRBA $14.42
- RGNX $8.27
- Resistance Level
- FRBA $15.29
- RGNX $9.32
- Average True Range (ATR)
- FRBA 0.36
- RGNX 0.49
- MACD
- FRBA -0.07
- RGNX -0.04
- Stochastic Oscillator
- FRBA 33.12
- RGNX 20.16
About FRBA First Bank
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.